Intermittent enzalutamide in recurrent prostate cancer: testosterone kinetics and related toxicity.

Marte JL, Hankin A, Williams M, Gulley JL, Karzai F, Bilusic M, Cordes L, Figg WD, Madan RA, Abel ML

Open source

DOI
10.1111/bju.70443
Published
2026 Sep 13
Container
BJU international
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/bju.70443,
  title = {Intermittent enzalutamide in recurrent prostate cancer: testosterone kinetics and related toxicity.},
  author = {Marte JL and Hankin A and Williams M and Gulley JL and Karzai F and Bilusic M and Cordes L and Figg WD and Madan RA and Abel ML},
  year = {2026},
  journal = {BJU international},
  doi = {10.1111/bju.70443},
  url = {https://doi.org/10.1111/bju.70443}
}

RIS

TY  - JOUR
TI  - Intermittent enzalutamide in recurrent prostate cancer: testosterone kinetics and related toxicity.
AU  - Marte JL
AU  - Hankin A
AU  - Williams M
AU  - Gulley JL
AU  - Karzai F
AU  - Bilusic M
AU  - Cordes L
AU  - Figg WD
AU  - Madan RA
AU  - Abel ML
PY  - 2026
JO  - BJU international
DO  - 10.1111/bju.70443
UR  - https://doi.org/10.1111/bju.70443
ER  - 

APA

JL, M., A, H., M, W., JL, G., F, K., M, B., L, C., WD, F., RA, M., & ML, A. (2026). Intermittent enzalutamide in recurrent prostate cancer: testosterone kinetics and related toxicity.. BJU international. https://doi.org/10.1111/bju.70443

Source records